|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-9-4
|
|
pubmed:abstractText |
The identification of new factors predicting relapse, outcome and response to systemic therapy in breast cancer is warranted. The measurement of biological markers such as drug resistance parameters (DRPs), which are part of the phenotype of malignant cells and contribute to resistance to anti-cancer drugs may be a possibility, which may ultimately lead to improvement of therapeutic results.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
335-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9209662-Adult,
pubmed-meshheading:9209662-Aged,
pubmed-meshheading:9209662-Aged, 80 and over,
pubmed-meshheading:9209662-Alkyl and Aryl Transferases,
pubmed-meshheading:9209662-Breast Neoplasms,
pubmed-meshheading:9209662-Drug Resistance,
pubmed-meshheading:9209662-Female,
pubmed-meshheading:9209662-Follow-Up Studies,
pubmed-meshheading:9209662-Glutathione,
pubmed-meshheading:9209662-Glutathione Peroxidase,
pubmed-meshheading:9209662-Humans,
pubmed-meshheading:9209662-Middle Aged,
pubmed-meshheading:9209662-Neoplasm Metastasis,
pubmed-meshheading:9209662-P-Glycoprotein,
pubmed-meshheading:9209662-Prognosis,
pubmed-meshheading:9209662-Transferases,
pubmed-meshheading:9209662-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics.
|
|
pubmed:affiliation |
Institute for Medical Oncology, Inselspital, Bern, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
